Home Procurement NewsAstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase

AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase

March 19, 2024•

The deal is AstraZeneca’s second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio.

Was this article helpful?

YesNo

Last modified: March 19, 2024

Previous: Grayscale CEO says fees on its bitcoin ETF will drop over time after outflows hit $12 billion

Next: Wike To Borrow N500 Billion To Finance 2024 FCT Budget

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The articles and content featured on this platform are sourced from various contributors and do not necessarily reflect the views or positions of Accountability Lab Nigeria. We do not author or edit the published materials. If you have concerns about any content or would like to request its removal, please contact us at @Accountability Lab Nigeria.

Recent Posts

Recent Comments

No comments to show.

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships

Accountability Lab Nigeria

Video Player

Media error: Format(s) not supported or source(s) not found

Download File: https://aclcop.cloudware.ng/wp-content/uploads/2025/03/Aclcop-2.mp4?_=1 Download File: https://aclcop.cloudware.ng/wp-content/uploads/2025/03/Aclcop-2.mp4?_=1

00:00

00:00

00:00

Use Up/Down Arrow keys to increase or decrease volume.

Copyright © 2021 - Accountability Lab Nigeria

Close